Current Rating Overview
MarketsMOJO currently assigns TCM Ltd a 'Sell' rating, reflecting a cautious stance on the stock. This rating was revised from 'Strong Sell' on 31 October 2025, accompanied by an improvement in the Mojo Score from 24 to 31. Despite this upward movement, the 'Sell' grade indicates that investors should remain wary of the stock’s risk profile and underlying fundamentals at present.
Here’s How TCM Ltd Looks Today
As of 26 December 2025, TCM Ltd remains a microcap player in the Commodity Chemicals sector, facing significant challenges in its financial health and operational performance. The company’s current Mojo Score of 31 places it in the lower tier of investment attractiveness, with a below-average quality grade and a risky valuation profile. However, technical indicators show a bullish trend, suggesting some positive momentum in the stock price despite fundamental weaknesses.
Quality Assessment
The quality grade for TCM Ltd is below average, primarily due to ongoing operating losses and weak long-term fundamental strength. The company’s ability to service debt is limited, as evidenced by a Debt to EBITDA ratio of -1.00 times, signalling negative earnings before interest, taxes, depreciation, and amortisation. This weak financial footing is further reflected in a negative return on capital employed (ROCE), underscoring inefficiencies in generating returns from invested capital.
Valuation Considerations
Valuation metrics currently classify TCM Ltd as risky. The stock trades at valuations that are elevated relative to its historical averages, which may deter value-focused investors. Despite this, the stock has delivered a 26.48% return over the past year as of 26 December 2025, indicating some market optimism. However, this return contrasts with the company’s negative earnings and operating cash flows, suggesting that price appreciation may be driven more by market sentiment than by fundamental improvements.
Register here to know the latest call on TCM Ltd
- - Fundamental Analysis
- - Technical Signals
- - Peer Comparison
Financial Trend and Profitability
The financial trend for TCM Ltd is negative, with recent quarterly results highlighting operational difficulties. As of 26 December 2025, the company reported a quarterly PAT loss of ₹0.78 crore, down 36.8% compared to previous periods. Operating cash flow for the year is deeply negative at ₹-10.79 crore, indicating cash burn and limited internal funding capacity. Net sales for the latest quarter stood at ₹5.92 crore, falling 14.20%, which points to weakening revenue streams.
Despite these challenges, the company’s profits have risen by 112.7% over the past year, a figure that appears contradictory but is likely influenced by base effects and accounting adjustments. The PEG ratio of 2.8 suggests that earnings growth is priced at a premium relative to the stock’s valuation, reinforcing the notion of elevated risk.
Technical Outlook
Technically, TCM Ltd exhibits a bullish grade, which contrasts with its fundamental weaknesses. The stock has shown strong momentum over the medium term, with a 3-month return of +41.40% and a 6-month return of +52.50% as of 26 December 2025. This technical strength may attract short-term traders and momentum investors, but it does not fully offset the underlying financial risks.
Stock Price Movement
On the day of this report, TCM Ltd’s stock price declined by 3.63%, continuing a recent trend of volatility. Over the past week, the stock has fallen 4.85%, and over the past month, it has declined 17.14%. These fluctuations highlight the stock’s sensitivity to market sentiment and the broader challenges facing the company.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
What the 'Sell' Rating Means for Investors
For investors, the 'Sell' rating on TCM Ltd signals caution. It suggests that the stock currently carries elevated risk due to weak fundamentals, negative financial trends, and a valuation that does not adequately compensate for these risks. While technical indicators show some bullish momentum, this should be weighed carefully against the company’s operational losses and cash flow challenges.
Investors considering TCM Ltd should closely monitor quarterly results and any shifts in the company’s debt servicing ability or profitability. The current rating advises a conservative approach, favouring either avoidance or reduction of exposure until clearer signs of financial recovery and sustainable growth emerge.
Summary
In summary, TCM Ltd’s 'Sell' rating as of 31 October 2025 reflects a nuanced view balancing modest technical strength against significant fundamental weaknesses. As of 26 December 2025, the company continues to face operational losses, risky valuations, and negative financial trends, despite some positive stock price momentum. Investors should remain vigilant and consider these factors carefully when making portfolio decisions involving TCM Ltd.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
